10X Genomics (TXG) shares slumped 26% pre-bell Thursday after the company reported preliminary Q3 sales that trailed analysts' projections.
E2open Parent Holdings (ETWO) shares dropped 22% after the company reported lower fiscal Q2 revenue and cut its full-year revenue guidance.
Mersana Therapeutics (MRSN) shares retreated 21%, adding to Wednesday's 5.5% loss.
Indivior (INDV) shares fell 17% after the company lowered its fiscal year 2024 revenue guidance.
Price: 15.39, Change: -5.42, Percent Change: -26.05
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。